Antares is a Scorpion Therapeutics spin-out developing small-molecule precision oncology drugs that leverage proprietary computational and experimental discovery to target previously inaccessible proteins, including transcription factors, with preclinical assets.
board.greenhouse.ioPart of: Boston tech scene from Fundable